Stock Fundamentals

Company Information

Company Name
ARS Pharmaceuticals, Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US82835W1080
CIK: 0001671858
CUSIP: 82835W108
Currency: USD
Full Time Employees: 154
Phone: 858 771 9307
Fiscal Year End: December
IPO Date: Dec 04, 2020
Description:

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.

Address:

11682 El Camino Real, San Diego, CA, United States, 92130

Directors & Officers

Name Title Year Born
Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL Co-Founder, CEO & Director 1966
Dr. Sarina Tanimoto M.B.A., M.D. Co-Founder & Chief Medical Officer 1969
Mr. Justin Chakma Chief Business Officer 1990
Mr. Donn Casale President 1973
Dr. Robert Bell Ph.D. Co-Founder & Chief Science Officer NA
Ms. Kathleen D. Scott CPA Chief Financial Officer NA
Mr. Brian T. Dorsey M.S. Chief Operating Officer 1969
Mr. Alexander A. Fitzpatrick Esq. Chief Legal Officer & Secretary 1967
Mr. Daniel Relovsky Senior Vice President of Marketing NA
Ms. Lynda Harris Vice President of Human Resources NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Nov 13, 2025 Brian Dorsey N/A Sale 21.83K $8.71 $190.12K
Nov 12, 2025 Justin Chakma N/A Sale 166.38K $8.87 $1.48M
Aug 21, 2025 Kathleen D Scott N/A Sale 12.50K $15.00 $187.50K
Aug 21, 2025 Richard E Lowenthal N/A Sale 50.00K $14.49 $724.50K
Aug 20, 2025 Sarina Tanimoto N/A Sale 37.66K $14.09 $530.57K
Aug 19, 2025 Sarina Tanimoto N/A Sale 12.34K $14.03 $173.19K
Jul 01, 2025 Eric Karas N/A Sale 15.00K $16.99 $254.85K
Jun 27, 2025 James E Flynn N/A Sale 740.15K $18.46 $13.66M
Jun 18, 2025 Eric Karas N/A Sale 15.00K $16.00 $240.00K
May 20, 2025 Alexander A Fitzpatrick N/A Sale 102.97K $14.10 $1.45M
May 20, 2025 Brent L. Saunders N/A Sale 120.00K $14.25 $1.71M
May 20, 2025 Kathleen D Scott N/A Sale 50.00K $14.10 $705.00K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
RA Capital Management, LLC 10.86M Mar 31, 2026 10.94% $0.92 0.00%
Orbimed Advisors, LLC 8.29M Mar 31, 2026 8.35% $1.32 0.00%
Rubric Capital Management LP 8.00M Mar 31, 2026 8.06% $0.68 29.03%
Deerfield Management Co 7.50M Mar 31, 2026 7.56% $0.71 0.00%
Millennium Management LLC 5.98M Mar 31, 2026 6.02% $0.02 88.83%
BlackRock Inc 5.01M Mar 31, 2026 5.05% $0.00 -1.44%
Aberdeen Group PLC 4.11M Mar 31, 2026 4.14% $0.05 15.68%
SR ONE CAPITAL MANAGEMENT, LP 4.01M Dec 31, 2025 4.04% $6.62 0.00%
State Street Corp 3.64M Mar 31, 2026 3.67% $0.00 13.07%
Vanguard Group Inc 3.51M Dec 31, 2025 3.53% $0.00 0.25%
Franklin Resources Inc 3.28M Mar 31, 2026 3.30% $0.01 28.92%
Tyro Capital Management LLC 2.97M Mar 31, 2026 2.99% $2.59 48.81%
Vanguard Capital Management, LLC 2.54M Mar 31, 2026 2.56% $0.00 0.00%
UBS Group AG 2.26M Mar 31, 2026 2.28% $0.00 2.24%
Janney Montgomery Scott LLC 2.02M Mar 31, 2026 2.03% $0.04 56.58%
Citadel Advisors Llc 1.77M Mar 31, 2026 1.79% $0.00 -9.28%
Geode Capital Management, LLC 1.53M Mar 31, 2026 1.54% $0.00 -1.68%
ADAR1 Capital Management LLC 1.36M Mar 31, 2026 1.37% $0.64 268.41%
BAMCO Inc 1.27M Mar 31, 2026 1.28% $0.03 0.38%
Third Point, LLC 1.00M Mar 31, 2026 1.01% $0.39 79.78%

Shares Statistics

Shares Outstanding: 99.30M
Shares Float: 42.45M
% Insiders: 1,620.70%
% Institutions: 9,546.70%
Short % Float: 37.04%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 State Street® SPDR® S&P® Biotech ETF 2.42M 2.44% ▼ 0.62% May 31, 2026
2 abrdn Healthcare Opportunities 1.78M 1.80% ▲ 0.00% Apr 30, 2026
3 Vanguard Total Stock Mkt Idx Inv 1.75M 1.76% ▲ 0.00% Apr 30, 2026
4 abrdn Healthcare Investors 1.57M 1.59% ▲ 1.72% May 31, 2026
5 iShares Russell 2000 ETF 1.41M 1.42% ▲ 0.93% May 29, 2026
6 Baron Discovery Strategy 1.07M 1.08% ▲ 0.00% Mar 31, 2026
7 Baron Discovery Institutional 1.07M 1.08% ▲ 0.00% Mar 31, 2026
8 Vanguard Institutional Extnd Mkt Idx Tr 739.03K 0.74% ▲ 0.58% Apr 30, 2026
9 Franklin US Small Cap Growth Equity 704.53K 0.71% ▲ 1,369.08% Mar 31, 2026
10 abrdn Life Sciences Investors 651.54K 0.66% ▲ 2.04% May 31, 2026

Valuation Metrics

Enterprise Value: $862.77M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $969.20M
EBITDA: $-200.93M
Book Value: $1.15
Earnings/Share: $-2.00
Profit Margin: -200.00%
Operating Margin: -265.18%
ROA (TTM): -41.15%
ROE (TTM): -136.40%
Revenue (TTM): $98.99M
Revenue/Share (TTM): $1.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 184.50%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 7.28x 0.85x 0.65x -69.05x -0.58x
2024-12-31 14.26x 0.00x 0.27x N/A 0.01x
2023-12-31 96.85x 0.00x 0.01x N/A 0.00x
2022-12-31 51.01x 0.00x 0.03x -42.59x -0.01x
2021-12-31 7.42x -0.27x 1.51x -183.53x -0.43x
2020-12-31 3.21x -0.71x 1.53x -16.17x -21.64x
2019-12-31 0.59x -2.19x 1.36x N/A -0.55x
2018-12-31 4.04x 0.19x 0.34x N/A -0.21x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about SPRY.US!